Our mission is to improve human health and well being through innovative diagnostic tests and global partnerships. Omega is focused on providing a wide range of specialist products, primarily in the ...
Our mission is to improve human health and well being through innovative diagnostic tests and global partnerships. Omega is focused on providing a wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease. Originally founded in Scotland in 1987 as Omega Diagnostics Ltd., by the current CEO, Andrew Shepherd, the company's global reputation stems from beginnings as a manufacturer of tests for a range of infectious diseases such as Syphilis, Dengue fever, Chagas disease and Malaria.